UNIVERSITY RESPONSE TO COVID-19 :
"Pandemics, Epidemics and Health Crises" with Dr. Edward Bilsky
Navigating Opioids, Pain Management and Substance Use Disorders in 2020
Join Dr. Ed Bilsky, Provost and Chief Academic Officer of Pacific Northwest University of Health Sciences (PNWU), and leader in the field of pain and opioids, for a fascinating and informative lecture on how the COVID-19 pandemic is impacting the opioid epidemic and the management of chronic pain.
See a recording of the virtual event below!
Dr. Edward Bilsky currently serves as the Provost and Chief Academic Officer at Pacific Northwest University of Health Sciences.
He received a Ph.D. in Pharmacology and Toxicology from the University of Arizona Colleges of Medicine and Pharmacy in 1996, with a concentration in opioid pharmacology, pain and addiction. As an assistant professor at the University of Northern Colorado, he received that institution’s highest honor, the Faculty Member of the Year in the spring of 2001, for his outstanding teaching, research and service to students. In the fall of 2001, he joined the faculty at the University of New England where he became a tenured Professor of Pharmacology and was the founding Director of the Center of Excellence in Neuroscience (CEN). The CEN incorporated research, education and outreach into its mission and vision and has created a robust community of neuroscientists and other scholars who are making meaningful contributions to their discipline, institution and community. More recently, he served as the Vice President for Research and Scholarship at UNE from 2011-2016. Under his leadership, UNE substantially grew the amount of external funding and scholarly output of the faculty and students, including major NIH and other health-related grants. At PNWU, he oversees teams who have achieved regional accreditation for the university and are creating vibrant new programs in physical and occupational therapy to complement the osteopathic medical school and initiatives in interprofessional education.
Dr. Bilsky engages a broad group of audiences on a variety of topics related to the neurobiology of pain, pain management and addiction to students in colleges of Osteopathic Medicine, Dental Medicine, Health Professions, Arts and Sciences and Pharmacy. He was awarded the 2011 AOA Research Mentor of the Year Award, was a finalist for the 2014 Council on Undergraduate Research Fellows award, a recipient of the Faculty for Undergraduate Neuroscience Lifetime Achievement Award and the 2014 Patient Advocacy Award from the American Academy of Pain Medicine. His advocacy efforts contributed to his selection as a 2019 Mayday Fellow where he expanded his outreach and public education activities with the goal of alleviating pain and suffering.
As a scientist, Dr. Bilsky’s laboratory conducted translational research in the areas of pain, addiction and other neurological disorders. He has published over 80 peer-reviewed publications in leading journals and has presented nationally and internationally in a variety of different venues. Dr. Bilsky co-founded two biotechnology companies that developed novel analgesics and other drugs to help manage opioid side effects. Part of this work brought a novel opioid antagonist into clinical trials. Both companies received SBIR phase I and II funding, and Dr. Bilsky has reviewed SBIRs and U grants for NIH study sections. As an expert in opioid pharmacology and early-stage drug discovery and development, he collaborates with scientists around the world and frequently consulted and conducted contracted work with biotechnology and pharmaceutical companies that have programs in analgesia and pain medicine.
This event is brought to you by the University of Bridgeport College of Health Sciences and the Connecticut Healthy Campus Initiative (CHCI).